Results 191 to 200 of about 25,852 (227)
CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER
Lancet, The, 1983 370 patients who had carcinoma of the breast with involved axillary lymph-nodes were randomised after total mastectomy and axillary clearance to receive either no additional treatment or melphalan 6 mg/m2 daily for 5 days every 6 weeks for sixteen cycles.
R D Rubens, R K Knight, I S Fentiman
exaly +3 more sources
Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis
Lancet, The, 1992 Both melphalan and cyclophosphamide increase life expectancy in patients with myelomatosis, but few large randomised studies have compared combination chemotherapy regimens with these single agents.
I C Maclennan, Janet Dunn
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches: